Literature DB >> 10549356

p53 and human cancer: the first ten thousand mutations.

P Hainaut1, M Hollstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10549356     DOI： 10.1016/s0065-230x(08)60785-x

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  287 in total

1.  A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.

Authors:  Assaf Friedler; Lars O Hansson; Dmitry B Veprintsev; Stefan M V Freund; Thomas M Rippin; Penka V Nikolova; Mark R Proctor; Stefan Rüdiger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

Review 2.  New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders.

Authors:  E Matutes
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

Review 3.  [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].

Authors:  T Longerich
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

4.  CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90.

Authors:  Stefan Rudiger; Stefan M V Freund; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

Review 5.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

6.  Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis.

Authors:  Guillermo de la Cueva-Méndez; Anthony D Mills; Lorena Clay-Farrace; Ramón Díaz-Orejas; Ronald A Laskey
Journal:  EMBO J       Date:  2003-01-15       Impact factor: 11.598

7.  Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Authors:  Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.

Authors:  Caroline M S Ekblad; Assaf Friedler; Dmitry Veprintsev; Richard L Weinberg; Laura S Itzhaki
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

9.  Regulation of p53 stability and function by the deubiquitinating enzyme USP42.

Authors:  Andreas K Hock; Arnaud M Vigneron; Stephanie Carter; Robert L Ludwig; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

10.  Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.

Authors:  Elke J A H van Beek; Jonathan M Hernandez; Debra A Goldman; Jeremy L Davis; Kaitlin McLaughlin; R Taylor Ripley; Teresa S Kim; Laura H Tang; Jaclyn F Hechtman; Jian Zheng; Marinela Capanu; Nikolaus Schultz; David M Hyman; Marc Ladanyi; Michael F Berger; David B Solit; Yelena Y Janjigian; Vivian E Strong
Journal:  Ann Surg Oncol       Date:  2018-05-03       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.